Contraceptive Use Among Women With Medical Conditions in a Nationwide Privately Insured Population
- 1 December 2015
- journal article
- other
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 126 (6) , 1151-1159
Abstract
OBJECTIVE: To examine contraceptive use among women with selected medical conditions. METHODS: We used a nationwide health care claims database to identify women aged 15–44 years continuously enrolled in private insurance during 2004–2011 with and without selected medical conditions. We assessed current permanent and reversible prescription contraceptive use during October 1, 2010, to September 30, 2011, with diagnosis, procedure, and pharmacy codes and calculated prevalence by age and condition. We used polytomous logistic regression to calculate odds of female sterilization or reversible prescription methods compared with neither. Among users of reversible methods, we used logistic regression to calculate odds of using long-acting reversible contraceptives compared with shorter acting methods. RESULTS: A low proportion of women with medical conditions were using sterilization or reversible prescription methods (45% and 30% of women aged 15–34 and 35–44 years, respectively), and this proportion was consistently lower among the older age group across all medical conditions. Across both age groups, sterilization and long-acting reversible contraceptives were used less frequently than shorter acting methods (injectable, pill, patch, or ring). The odds of sterilization were higher among women with any compared with no condition for women aged 15–34 years (odds ratio [OR] 4.9, 95% confidence interval [CI], 4.5–5.3) and 35–44 years (OR 1.2, 95% CI, 1.1–1.2). Among women using reversible prescription methods, the odds of using long-acting reversible contraceptives were increased among those with any compared with no condition for women aged 15–34 years (OR 2.2, 95% CI, 2.1–2.5) and 35–44 years (OR 1.1, 95% CI, 1.1–1.2). CONCLUSION: Despite the potential for serious maternal and fetal pregnancy-associated risks, contraceptive use was not optimal among women with medical conditions. LEVEL OF EVIDENCE: IIIKeywords
This publication has 14 references indexed in Scilit:
- Receipt of Prescription Contraception by Commercially Insured Women With Chronic Medical ConditionsObstetrics & Gynecology, 2014
- Shifts in Intended and Unintended Pregnancies in the United States, 2001–2008American Journal of Public Health, 2014
- Unintended pregnancy and postpartum contraceptive use in women with and without chronic medical disease who experienced a live birthContraception, 2011
- Contraceptive failure in the United StatesContraception, 2011
- Hormonal contraception use and pregnancy in adolescents with sickle cell disease: analysis of Michigan Medicaid claimsContraception, 2011
- Overview of Maternal Morbidity During Hospitalization for Labor and Delivery in the United StatesObstetrics & Gynecology, 2009
- The Effects of Unintended Pregnancy on Infant, Child, and Parental Health: A Review of the LiteratureStudies in Family Planning, 2008
- Contemporary risks of maternal morbidity and adverse outcomes with increasing maternal age and pluralityFertility and Sterility, 2007
- Contraceptive use by diabetic and obese womenWomen's Health Issues, 2005
- Identifying Persons with Diabetes Using Medicare Claims DataAmerican Journal of Medical Quality, 1999